U.S. markets close in 2 hours 43 minutes

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
313.58+9.60 (+3.16%)
As of 10:16AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Engulfing Line (Bearish)

Engulfing Line (Bearish)

Previous Close303.98
Open305.00
Bid311.00 x 1300
Ask311.24 x 800
Day's Range304.07 - 313.86
52 Week Range196.78 - 404.20
Volume182,005
Avg. Volume1,548,681
Market Cap45.783B
Beta (5Y Monthly)1.11
PE Ratio (TTM)72.69
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
11% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Illumina to Webcast Upcoming Investor Conference Presentation
    Business Wire

    Illumina to Webcast Upcoming Investor Conference Presentation

    Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

  • Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit
    Business Wire

    Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit

    . Illumina, Inc. (NASDAQ: ILMN) is further extending the reach of the NextSeq™ 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The P3 flow cell offers 1.1 billion reads in a single sequencing run, almost three times more than previously available on Illumina’s mid-throughput NextSeq sequencing portfolio, expanding the range of applications that run on the system.

  • Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA
    Business Wire

    Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA

    Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASDAQ: ILMN) and Western Digital (NASDAQ: WDC) today announced the formation of an alliance with Microsoft to advance the field of DNA data storage. These founding companies, alongside member organizations, will work together to create a comprehensive industry roadmap that will help the industry achieve interoperability between solutions and help establish the foundations for a cost-effective commercial archival storage ecosystem for the explosive growth of digital data.